Perfil
Janice Marie McCourt is currently the Chief Executive Officer at Hudson Therapeutics, Inc. and the Chief Business Officer at Comera Life Sciences Holdings, Inc. Her former positions include Vice President-Business Development at Agenus, Inc., Scorpius Holdings, Inc., and Chief Business & Corporate Development Officer at Lyvgen Biopharma Holdings Ltd. She completed her undergraduate degree at Massachusetts College of Pharmacy & Health Science and holds an MBA from the University of Phoenix.
Cargos activos de Janice McCourt
| Empresas | Cargo | Inicio |
|---|---|---|
| COMERA LIFE SCIENCES HOLDINGS, INC. | Corporate Officer/Principal | 09/11/2022 |
Antiguos cargos conocidos de Janice McCourt.
| Empresas | Cargo | Fin |
|---|---|---|
| SCORPIUS HOLDINGS, INC. | Corporate Officer/Principal | 01/01/2019 |
Lyvgen Biopharma Holdings Ltd | Corporate Officer/Principal | - |
| AGENUS INC. | Corporate Officer/Principal | - |
Formación de Janice McCourt.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Agenus, Inc.
Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Scorpius Holdings, Inc.
Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
Massachusetts College of Pharmacy & Health Science
Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Phoenix
University of Phoenix Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Comera Life Sciences Holdings, Inc.
Comera Life Sciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
Lyvgen Biopharma Holdings Ltd |
- Bolsa de valores
- Insiders
- Janice McCourt
















